Shuta Tomida

Author PubWeight™ 62.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004 18.86
2 A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005 10.46
3 Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005 4.55
4 Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013 3.32
5 Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 2007 2.59
6 Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006 2.37
7 Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 2004 1.89
8 NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 2012 1.68
9 An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One 2012 1.34
10 Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 2008 1.30
11 A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst 2007 1.30
12 MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J 2011 1.17
13 miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 2011 1.10
14 Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics 2004 1.03
15 Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain. Biomed Res Int 2013 0.98
16 Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses. Cancer Res 2009 0.94
17 Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions. Oncotarget 2014 0.92
18 Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas. Mol Carcinog 2011 0.91
19 Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. Cancer Res 2010 0.88
20 PCNA mono-ubiquitination and activation of translesion DNA polymerases by DNA polymerase {alpha}. J Biochem 2009 0.85
21 The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. ISME J 2015 0.81
22 Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutation. J Thorac Oncol 2015 0.81
23 Inference of common genetic network using fuzzy adaptive resonance theory associated matrix method. J Biosci Bioeng 2003 0.81
24 Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. BMC Microbiol 2012 0.80
25 Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. Mol Cancer 2014 0.80
26 Seven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis. Int J Proteomics 2012 0.79
27 Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathways. Cancer Res 2010 0.79
28 DIAMETER is a KEY 3D CHARACTERISTIC for ASSESSMENTS of EFFICIENT INHIBITORS of PROTEIN-PROTEIN INTERACTIONS. J Chem Inf Model 2020 0.75